Election 2014
SENSEX NIFTY

Divis

Apr 16, 2014 at 09:12 | Source: Moneycontrol.com
According to Way2Wealth, after yesterdays sell-off, today markets will open on flat note and thereafter is expected to trade in narrow band of 30-40 points.
Apr 11, 2014 at 09:57 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, pharma stocks like Divis Labs, Sun Pharma,Ranbaxy, Strides Arcolab and Cipla will get astrological support.
Apr 03, 2014 at 14:50 | Source: CNBC-TV18
Sahil Kapoor of Edelweiss RCM Research is of the view that one may pick Aurobindo Pharma and Divis Laboratories from the pharma space.
Mar 31, 2014 at 18:06 | Source: Moneycontrol.com
In terms of individual stocks Amara Raja batteries was the top holding with Federal bank, Divis labs, Gateway Distriparks, IPCA labs, ICICI Bank Apollo Tyres and GMDC being some other holdings.
Mar 13, 2014 at 10:55 | Source: CNBC-TV18
According to Sudarshan Sukhani of s2analytics.com, one may go long in Divis Laboratories on dips as the stock may test lifetime new highs.
Mar 06, 2014 at 13:33 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one may prefer Divis Laboratories.
Mar 04, 2014 at 14:22 | Source: CNBC-TV18
Dharmesh Kant of Indianivesh Securities recommends buying UPL for a target of Rs 210 and Divis Laboratories for a target of Rs 1500.
Mar 04, 2014 at 14:18 | Source: CNBC-TV18
According to Vishal Malkan of malkansview.com, one may buy Idea Cellular with a target of Rs 138 and advises selling Jain Irrigation Systems with a target of Rs 57.
Mar 04, 2014 at 08:47 | Source: CNBC-TV18
Dharmesh Kant, Indianivesh Securities advises buying Bank of India for a target price of Rs 190 and Bharat Forge for a target price of Rs 410.
Mar 03, 2014 at 10:03 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, pharma stocks like Sun Pharmaceutical Industries, Divis Laboratories, Cipla, Biocon, Aurobindo Pharma and JB Chemicals and Pharmaceuticals will get astrological support.
Messages on Divis »

ashport

Platinum Member

352 Followers

MF Investment Help  

Nifty is up almost 2%, HDFC is down 1.5 %. Its other top 5 holdings are Divis Lab, Good year, 3M India, P&G hygiene and Page Industries which together constitutes more than 30% of the portfolio. That means top 6 stocks almost accounts 40 % of the portfolio. So if this fund has to do well in near future

3.16 PM Apr 17th

Bprao

New Member

0 Follower

Divis Laboratories  

On Monday you don`t get Divis at current price. So one can buy today.

2.17 PM Apr 17th

Bprao

New Member

0 Follower

Divis Laboratories  

Divis is available at low price. It is sure to participate in the rally and reach 1480 by 22nd Tuesday.

1.37 PM Apr 17th

rise95

Platinum Member

88 Followers

Tech Mahindra  

Many Merged companies rated best PE and offered handsome DIVI than peers!

1.22 PM Apr 17th

rise95

Platinum Member

88 Followers

Tech Mahindra  

I expect as This result is different as the first A Result of the merged TM giving direction to the world,,a show of their ability to perform at areas they wish to SHOW the world recognise!!Special one time divi of 50 also possible!

1.16 PM Apr 17th

bullguru108

Platinum Member

975 Followers

Tech Mahindra  

first milestone May annual results and solid divy announcement.

1.39 PM Apr 16th

bullguru108

Platinum Member

975 Followers

Tech Mahindra  

wnt b once we get solid divy announcemt come May 14

1.33 PM Apr 16th

AMJAD602

New Member

0 Follower

Divis Labs  

No comments.... - My target for Divis Labs is Rs 1312 for intraday with a stoploss of Rs 1330

12.50 PM Apr 16th

rise95

Platinum Member

88 Followers

Tech Mahindra  

Massive divi on grant success of merger on first a result

11.23 AM Apr 15th

carya1

Platinum Member

239 Followers

Unitech  

Chandra at sc unitecj at allahbad court,,no divi,this time too,,

3.56 PM Apr 14th

News across the web »
Apr 16, 2014 at 13:10 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.